Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
6.71
-0.20 (-2.89%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Starling Oncology Market Cap
Starling Oncology has a market cap or net worth of $683.86 million as of October 23, 2026. It is the 12,463rd most valuable company in the world and the 2,504th biggest in the United States. Its market cap has increased by 66.60% in one year.
Market Cap
683.86M
Enterprise Value
747.56M
1-Year Change
66.60%
Global Rank
Country Rank
#2,504 United States
Category
ChartMarket Cap Chart
Since July 23, 2021, Starling Oncology's market cap has increased from $990.00 to $683.86M, an increase of 69,076,377.98%. That is a compound annual growth rate of 1,191.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 683.86M | 95.26% |
| Dec 31, 2025 | 350.24M | 1,400.09% |
| Dec 31, 2024 | 23.35M | -84.48% |
| Dec 29, 2023 | 150.45M | 22.52% |
| Dec 30, 2022 | 122.80M | -82.81% |
| Dec 31, 2021 | 714.18M | 72,139,108.08% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| COMPASS Pathways | 1.55B |
| agilon health | 1.51B |
| The Pennant Group | 1.46B |
| Nutex Health | 1.44B |
| U.S. Physical Therapy | 1.32B |
| InnovAge Holding | 1.30B |
| GMR Solutions | 833.95M |
| Charming Medical | 504.26M |